EMA Backs Oral Drug for Primary Biliary Cholangitis ...Middle East

Medscape - News
Iqirvo can delay liver fibrosis and cirrhosis in patients with primary biliary cholangitis, the European Medicines Agency decided. Medscape Medical News

Hence then, the article about ema backs oral drug for primary biliary cholangitis was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( EMA Backs Oral Drug for Primary Biliary Cholangitis )

Apple Storegoogle play

Last updated :

Also on site :



Latest News